Equities

SkinBioTherapeutics PLC

SBTX:LSE

SkinBioTherapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)20.25
  • Today's Change-0.75 / -3.57%
  • Shares traded487.12k
  • 1 Year change8.00%
  • Beta1.8880
Data delayed at least 20 minutes, as of Feb 06 2026 15:31 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2025, SkinBioTherapeutics PLC increased its cash reserves by 496.76%, or 3.98m. Cash Flow from Financing totalled 6.83m or 147.36% of revenues. In addition the company used 1.24m for operations while cash used for investing totalled 1.62m.
Cash flow per share-0.0012
Price/Cash flow per share--
Book value per share0.0364
Tangible book value per share0.0198
More ▼

Balance sheet in GBPView more

SkinBioTherapeutics PLC appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio4.84
Quick ratio4.29
Total debt/total equity0.1055
Total debt/total capital0.0954
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.